Table 1.
Patient clinicopathologic features and microvessel area parameters
| Clinicopathologic variables | Patients (%) | MVA | p value* | SnMVA (× 10-6) | p value* |
|---|---|---|---|---|---|
| Age | |||||
| <60 | 51 (51.0) | 0.0257 ± 0.0169 | 0.472 | 0.0584 ± 0.0507 | 0.999 |
| ≥60 | 49 (49.0) | 0.0289 ± 0.0264 | 0.0584 ± 0.0469 | ||
| Gender | |||||
| Male | 74 (74.0) | 0.0286 ± 0.0241 | 0.307 | 0.0630 ± 0.0531 | 0.116 |
| Female | 26 (26.0) | 0.0234 ± 0.0142 | 0.0455± 0.0299 | ||
| Smoking history | |||||
| Never | 33 (33.0) | 0.0276 ± 0.0261 | 0.349 | 0.0514±0.0335 | 0.315 |
| Prior or current | 67 (67.0) | 0.0256 ± 0.0169 | 0.0619±0.0545 | ||
| Disease stage | |||||
| Early (stage I & II) | 71 (71.0) | 0.0281 ± 0.0245 | 0.531 | 0.0614± 0.0530 | 0.348 |
| Advanced (stage III & IV) | 29 (29.0) | 0.0251 ± 0.0143 | 0.0513 ± 0.0357 | ||
| Tumor histology | |||||
| Adenocarcinoma | 54 (54.0) | 0.0285 ± 0.0251 | 0.679 | 0.0593±0.0460 | 0.519 |
| Squamous | 43 (43.0) | 0.0252 ± 0.0182 | 0.0553±0.0528 | ||
| Others | 3 (3.0) | 0.0335 ± 0.00664 | 0.0884± 0.0283 | ||
| Tumor differentiation | |||||
| Poorly | 49 (49.0) | 0.0243 ± 0.01408 | 0.659 | 0.0529± 0.0476 | 0.366 |
| Moderately | 47 (47.0) | 0.0287 ± 0.02494 | 0.0621 ±0.0508 | ||
| Well | 1 (1.0) | 0.0697 | 0.0665 | ||
| Chemotherapy | 0.924 | 0.443 | |||
| Mono-line | 68 (68.0) | 0.0284 ± 0.0242 | 0.0593 ± 0.0496 | ||
| Multi-lines | 13 (13.0) | 0.0290 ± 0.0175 | 0.0475 ± 0.0446 | ||
| Total | 0.0273 ± 0.0220 | 0.0584 ±0.0487 | |||